(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1637659

欧州のオピオイド市場：2030年までの予測 - 地域別分析 - 製品別、用途別、投与経路別、流通チャネル別

Europe Opioids Market Forecast to 2030 - Regional Analysis - by Product, Application, Route of Administration, and Distribution Channel
PrevNext
1
2
3
4

出版日
ページ情報
英文 90 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
欧州のオピオイド市場：2030年までの予測 - 地域別分析 - 製品別、用途別、投与経路別、流通チャネル別
出版日: 2024年11月22日
発行: The Insight Partners
ページ情報: 英文 90 Pages
納期: 即納可能 即納可能とは
PrevNext
1
2
3
4
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のオピオイド市場は、2022年に45億5,386万米ドルとなり、2030年までには52億3,772万米ドルに達すると予測され、2022年から2030年までのCAGRは1.8%と推定されます。

慢性疼痛の急増が欧州のオピオイド市場を牽引

心血管疾患、がん、筋骨格系疾患、神経血管疾患などの慢性疾患は、免疫力を低下させることで人の健康に重大な影響を与えます。さらに、これらの疾患を患う患者の多くが慢性的な痛みを経験しています。上記のような疾患は、成人や老人に多く見られます。しかし、これらの病気は子供にも増えています。慢性疼痛は、スポーツ選手やアスリート、過去に怪我をした人にもよく見られます。NCBI（i.e.国立生物工学情報センター）に掲載された研究によると、世界中で成人の20％が痛みに苦しんでおり、年間10％が新たに慢性疼痛と診断されています。痛みは、性別、人種／民族、収入、年齢、地域に関係なく、すべての人々に影響を及ぼしますが、世界中に均等に分布しているわけではありません。ヒドロコドン、オキシコドン、モルヒネなどの処方オピオイドは、強力な鎮痛薬であり、怪我や手術、がんや関節炎などの健康状態による痛みの治療に使用されます。オピオイド処方の増加は、代替疼痛治療よりもオピオイドを奨励する保険償還プログラム、より効率的な治療を奨励するコスト構造、患者の満足度と効果的な疼痛管理を組み合わせた評価などに起因しています。そのため、疼痛管理におけるオピオイドの優位性により、慢性疾患患者の間で需要が高まっています。

欧州のオピオイド市場の概要

欧州のオピオイド市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。欧州はオピオイド市場で重要な位置を占めており、予測期間中に力強い市場成長が見込まれます。同地域の市場成長の主な要因は、慢性疼痛を引き起こす疾患（関節炎、腰痛、線維筋痛症など）の有病率が上昇していることと、オピオイド薬（ヘロインなど）の中毒を治療する薬が急増していることです。例えば、メタドンは欧州で最も処方されているオピオイド作動薬であり、オピオイド作動薬維持療法の患者の75％に使用されています。ブプレノルフィンは、この地域で2番目に多く使用されているオピオイド作動薬です。しかし、クロアチア、キプロス、チェコ共和国、フィンランド、フランス、スウェーデンでは、最も頻繁に使用されているオピオイド維持治療の一つです。キプロスとドイツではコデインが主要な作動薬として使用されていますが、ベルギー、デンマーク、ドイツ、オランダ、スペイン、英国、アイルランドではジアセチルモルヒネがよく使用されています。

欧州のオピオイド市場の収益と2030年までの予測（金額）

欧州のオピオイド市場のセグメンテーション

欧州のオピオイド市場は、製品、用途、投与経路、流通チャネル、国に分類されます。

製品に基づき、欧州のオピオイド市場は、即時放出型短時間作用型オピオイドと徐放型長時間作用型オピオイドに区分されます。2022年の市場シェアは、即時放出短時間作用型オピオイドセグメントが大きいです。即放性短時間作用型オピオイドはさらにオキシコドン、ヒドロコドン、トラマドール、コデイン、プロポキシフェン、その他に細分化されます。徐放性長時間作用型オピオイドは、さらにオキシコドン、フェンタニル、モルヒネ、メタドン、その他に細分化されます。

用途別では、欧州のオピオイド市場は疼痛管理、麻酔、下痢抑制、咳抑制、脱中毒、その他に分類されます。2022年には疼痛管理分野が最大の市場シェアを占めました。

投与経路別では、欧州のオピオイド市場は経口剤、注射剤、経皮パッチ剤に区分されます。経口剤が2022年に最大の市場シェアを占めました。

流通チャネル別では、欧州のオピオイド市場は病院薬局と小売薬局に二分されます。病院薬局セグメントが2022年に大きな市場シェアを占めました。

国別では、欧州のオピオイド市場は英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。2022年の欧州のオピオイド市場シェアは英国が独占しました。

Endo International plc、Mallinckrodt Plc、Neuraxpharm Pharmaceuticals SL、Hikma Pharmaceuticals Plc、Rusan Pharma Ltd、Teva Pharmaceutical Industries Ltdなどが欧州のオピオイド市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のオピオイド市場-主要市場力学

  • 市場促進要因
    • 慢性疼痛の急増
    • 高齢者人口の増加
  • 市場抑制要因
    • 薬物乱用の増加
  • 市場機会
    • 市場プレイヤーの戦略的取り組み
  • 促進要因と抑制要因の影響

第5章 オピオイド市場：欧州分析

  • 欧州のオピオイド市場概要
  • 欧州のオピオイド市場収益、2020年～2030年
  • 欧州のオピオイド市場予測分析

第6章 欧州のオピオイド市場分析：製品別

  • 即放性短時間作用型オピオイド
  • 徐放性長時間作用型オピオイド

第7章 欧州のオピオイド市場分析：用途別

  • 疼痛管理
  • 麻酔薬
  • 下痢抑制
  • 咳止め
  • 脱中毒
  • その他

第8章 欧州のオピオイド市場分析：投与経路別

  • 経口剤
  • 注射剤
  • 経皮パッチ

第9章 欧州のオピオイド市場分析：流通経路別

  • 病院薬局
  • 小売薬局

第10章 欧州のオピオイド市場：国別分析

  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他欧州

第11章 業界情勢

  • オピオイド市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
    • 成長戦略

第12章 企業プロファイル

  • Endo International plc
  • Mallinckrodt Plc
  • Neuraxpharm Pharmaceuticals SL
  • Hikma Pharmaceuticals Plc
  • Rusan Pharma Ltd
  • Teva Pharmaceutical Industries Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Europe Opioids Market Segmentation
  • Table 2. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 4. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 5. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 6. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 7. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 8. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 9. Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 10. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 11. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 12. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 13. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 14. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 15. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 16. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 17. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 18. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 19. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 20. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 21. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 22. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 23. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 24. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 25. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 27. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 28. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 29. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 30. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 31. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 32. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 33. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 34. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 35. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 36. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 37. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 38. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 39. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 40. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 41. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 42. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 43. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 44. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 45. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 46. Recent Organic Growth Strategies in Opioids Market
  • Table 47. Recent Inorganic Growth Strategies in the Opioids Market
  • Table 48. Glossary of Terms, Opioids Market

List Of Figures

  • Figure 1. Europe Opioids Market Segmentation, by Country
  • Figure 2. Europe Opioids Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Opioids Market Revenue (US$ Million), 2020-2030
  • Figure 5. Europe Opioids Market Share (%) - by Product (2022 and 2030)
  • Figure 6. Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Europe Opioids Market Share (%) - by Application (2022 and 2030)
  • Figure 9. Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Europe Opioids Market Share (%) - by Route of Administration (2022 and 2030)
  • Figure 16. Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Europe Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 20. Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Europe: Opioids Market Breakdown, by Key Countries - Revenue (2022) (US$ Million)
  • Figure 23. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 24. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Growth Strategies in Opioids Market
目次
Product Code: BMIRE00030996

The Europe opioids market was valued at US$ 4,553.86 million in 2022 and is expected to reach US$ 5,237.72 million by 2030; it is estimated to register a CAGR of 1.8% from 2022 to 2030.

Surging Chronic Pain Incidence Drive Europe Opioids Market

Chronic diseases such as cardiovascular disease, cancer, musculoskeletal diseases, and neurovascular diseases critically affect a person's health by lowering immunity. Moreover, many patients suffering from these conditions experiences chronic pain. The diseases mentioned above are most common in adults and the geriatric population. Nevertheless, cases of these diseases are noticeably growing among children as well. Chronic pain is also common among sportspersons, athletes, and individuals living with past injuries. According to a study published in the NCBI (i.e., National Center for Biotechnology Information), 20% of adults suffer from pain worldwide, and 10% are newly diagnosed with chronic pain per year. While pain affects all populations, regardless of sex, race/ethnicity, income, age, or geography, it is not distributed equally across the world. Prescription opioids, including hydrocodone, oxycodone, and morphine, are potent pain-reducing medications that are used to treat pain caused by injuries, surgeries, and health conditions such as cancer and arthritis. Increased opioid prescribing practices can be attributed to the insurance reimbursement programs that incentivize opioids over alternative pain treatments, cost structures that encourage more efficient care, and evaluations that combine patient satisfaction with effective pain management. Therefore, owing to the advantage of opioids in pain management, the demand is rising among patients with chronic diseases.

Europe Opioids Market Overview

The Europe opioids market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the Europe opioids market and is expected to experience strong market growth during the forecast period. The market growth in the region is mainly attributed to the rising prevalence of diseases that cause chronic pain (such as arthritis, lower back pain, and fibromyalgia) and the surging availability of medications to treat addiction to opioid drugs (such as heroin). For instance, methadone is the most prescribed opioid agonist in Europe and is used in 75% of patients for opioid agonist maintenance treatment. Buprenorphine is the second most used opioid agonist in the region. However, it is one of the most often used opioid maintenance treatments in Croatia, Cyprus, the Czech Republic, Finland, France, and Sweden. Codeine is the primary agonist used in Cyprus and Germany, whereas diacetylmorphine is the one that is commonly used in Belgium, Denmark, Germany, the Netherlands, Spain, the UK, and Ireland.

Europe Opioids Market Revenue and Forecast to 2030 (US$ Million)

Europe Opioids Market Segmentation

The Europe opioids market is categorized into product, application, route of administration, distribution channel, and country.

Based on product, the Europe opioids market is segmented immediate release short acting opioid and extended release long acting opioid. The immediate release short acting opioid segment held a larger market share in 2022. The immediate release short acting opioid is further sub segmented into oxycodone, hydrocodone, tramadol, codeine, propoxyphene, and others. The extended release long acting opioid is further sub segmented into oxycodone, fentanyl, morphine, methadone, and others.

In terms of application, the Europe opioids market is categorized into pain management, anesthesia, diarrhea suppression, cough suppression, de-addiction, and others. The pain management segment held the largest market share in 2022.

By route of administration, the Europe opioids market is segmented into oral, injectable, and transdermal patch. The oral segment held the largest market share in 2022.

By distribution channel, the Europe opioids market is bifurcated into hospital pharmacies and retail pharmacies. The hospital pharmacies segment held a larger market share in 2022.

By country, the Europe opioids market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK dominated the Europe opioids market share in 2022.

Endo International plc, Mallinckrodt Plc, Neuraxpharm Pharmaceuticals SL, Hikma Pharmaceuticals Plc, Rusan Pharma Ltd, and Teva Pharmaceutical Industries Ltd are some of the leading companies operating in the Europe opioids market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Opioids Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Surging Chronic Pain Incidence
    • 4.1.2 Increasing Geriatric Population
  • 4.2 Market Restraints
    • 4.2.1 Increasing Drug Abuse
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Market Players
  • 4.4 Impact of Drivers and Restraints:

5. Opioids Market - Europe Analysis

  • 5.1 Europe Opioids Market Overview
  • 5.2 Europe Opioids Market Revenue (US$ Million), 2020-2030
  • 5.3 Europe Opioids Market Forecast Analysis

6. Europe Opioids Market Analysis - by Product

  • 6.1 Immediate Release Short Acting Opioid
    • 6.1.1 Overview
    • 6.1.2 Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.1.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • 6.2 Extended Release Long-Acting Opioid
    • 6.2.1 Overview
    • 6.2.2 Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.2.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

7. Europe Opioids Market Analysis - by Application

  • 7.1 Pain Management
    • 7.1.1 Overview
    • 7.1.2 Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Anesthesia
    • 7.2.1 Overview
    • 7.2.2 Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Diarrhea Suppression
    • 7.3.1 Overview
    • 7.3.2 Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Cough Suppression
    • 7.4.1 Overview
    • 7.4.2 Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 De-Addiction
    • 7.5.1 Overview
    • 7.5.2 De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Opioids Market Analysis - by Route of Administration

  • 8.1 Oral
    • 8.1.1 Overview
    • 8.1.2 Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Injectable
    • 8.2.1 Overview
    • 8.2.2 Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Transdermal Patch
    • 8.3.1 Overview
    • 8.3.2 Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Opioids Market Analysis - by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Overview
    • 9.1.2 Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Retail Pharmacies
    • 9.2.1 Overview
    • 9.2.2 Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Opioids Market - Country Analysis

  • 10.1 Europe
    • 10.1.1 Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
      • 10.1.1.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 United Kingdom: Europe Opioids Market Breakdown, by Product
        • 10.1.1.2.2 United Kingdom: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.2.3 United Kingdom: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.2.4 United Kingdom: Europe Opioids Market Breakdown, by Application
        • 10.1.1.2.5 United Kingdom: Europe Opioids Market Breakdown, by Route of Administration
        • 10.1.1.2.6 United Kingdom: Europe Opioids Market Breakdown, by Distribution Channel
      • 10.1.1.3 Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Germany: Europe Opioids Market Breakdown, by Product
        • 10.1.1.3.2 Germany: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.3.3 Germany: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.3.4 Germany: Europe Opioids Market Breakdown, by Application
        • 10.1.1.3.5 Germany: Europe Opioids Market Breakdown, by Route of Administration
        • 10.1.1.3.6 Germany: Europe Opioids Market Breakdown, by Distribution Channel
      • 10.1.1.4 France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 France: Europe Opioids Market Breakdown, by Product
        • 10.1.1.4.2 France: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.4.3 France: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.4.4 France: Europe Opioids Market Breakdown, by Application
        • 10.1.1.4.5 France: Europe Opioids Market Breakdown, by Route of Administration
        • 10.1.1.4.6 France: Europe Opioids Market Breakdown, by Distribution Channel
      • 10.1.1.5 Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Italy: Europe Opioids Market Breakdown, by Product
        • 10.1.1.5.2 Italy: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.5.3 Italy: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.5.4 Italy: Europe Opioids Market Breakdown, by Application
        • 10.1.1.5.5 Italy: Europe Opioids Market Breakdown, by Route of Administration
        • 10.1.1.5.6 Italy: Europe Opioids Market Breakdown, by Distribution Channel
      • 10.1.1.6 Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Spain: Europe Opioids Market Breakdown, by Product
        • 10.1.1.6.2 Spain: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.6.3 Spain: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.6.4 Spain: Europe Opioids Market Breakdown, by Application
        • 10.1.1.6.5 Spain: Europe Opioids Market Breakdown, by Route of Administration
        • 10.1.1.6.6 Spain: Europe Opioids Market Breakdown, by Distribution Channel
      • 10.1.1.7 Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.7.1 Rest of Europe: Opioids Market Breakdown, by Product
        • 10.1.1.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.7.4 Rest of Europe: Opioids Market Breakdown, by Application
        • 10.1.1.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
        • 10.1.1.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Opioids Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Endo International plc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Mallinckrodt Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Neuraxpharm Pharmaceuticals SL
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Hikma Pharmaceuticals Plc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Rusan Pharma Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Teva Pharmaceutical Industries Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms